EIF4E - eukaryotic translation initiation factor 4E Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 487870
EIF4E Products (7)
| mRNA | Protein | Name |
|---|---|---|
| XM_038444214.1 | XP_038300142.1 | eukaryotic translation initiation factor 4E isoform X4 |
| XM_038444212.1 | XP_038300140.1 | eukaryotic translation initiation factor 4E isoform X3 |
| XM_038444210.1 | XP_038300138.1 | eukaryotic translation initiation factor 4E isoform X3 |
| XM_038444211.1 | XP_038300139.1 | eukaryotic translation initiation factor 4E isoform X3 |
| XM_038444213.1 | XP_038300141.1 | eukaryotic translation initiation factor 4E isoform X3 |
| XM_038444209.1 | XP_038300137.1 | eukaryotic translation initiation factor 4E isoform X2 |
| XM_038444208.1 | XP_038300136.1 | eukaryotic translation initiation factor 4E isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
eukaryotic translation initiation factor 4E |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-100022 | Tomivosertib | Inhibitor | 99.92% | Phase 2 |
| HY-16366 | Briciclib | 99.45% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(42)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-19831 | 4EGI-1 | 98.69% | Unkown | |
| HY-145974A | m7GpppAmpG ammonium solution (100 mM) | 99.96% | Unkown | |
| HY-14427 | 4E1RCat | Inhibitor | 99.04% | Unkown |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | 41.20% | Unkown | |
| HY-145262 | eIF4E-IN-2 | Inhibitor | 98.91% | Unkown |
| HY-145969A | β-S-ARCA triammonium | 99.48% | Unkown | |
| HY-100733 | 4E2RCat | Inhibitor | 98.0% | Unkown |
| HY-119271 | CMLD010509 | 99.11% | Unkown | |
| HY-19831A | (Z)-4EGI-1 | Inhibitor | 98.0% | Unkown |
| HY-176428 | PROTAC MNK1 degrader-1 | 98.93% | Unkown | |
| HY-146805 | EB1 | 99.91% | Unkown | |
| HY-RS04274 | EIF4E Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-114267 | Cbz-B3A | Inhibitor | 98.63% | Unkown |
| HY-148105 | DS12881479 | 99.63% | Unkown | |
| HY-145309 | eIF4E-IN-3 | Inhibitor | / | Unkown |
| HY-145969 | β-S-ARCA | / | Unkown | |
| HY-139098A | 7-Methyl-diguanosine triphosphate ammonium solution (100 mM) | 98.83% | Unkown | |
| HY-178672A | ARCA triammonium solution (100 mM) | / | Unkown | |
| HY-100022A | Tomivosertib hydrochloride | Inhibitor | / | Unkown |
| HY-145240 | eIF4E-IN-1 | Inhibitor | / | Unkown |
| HY-145974AGL | m7GpppAmpG ammonium solution (100 mM) (GMP like) | / | Unkown | |
| HY-148664 | eIF4E-IN-4 | Inhibitor | / | Unkown |
| HY-155337 | eIF4E-IN-6 | Inhibitor | / | Unkown |
| HY-155676 | eIF4E-IN-5 | Inhibitor | / | Unkown |
| HY-163479 | MNK1/2-IN-7 | Inhibitor | / | Unkown |
| HY-16366A | Briciclib sodium | / | Unkown | |
| HY-176288 | eIF4E/eIF4G PPI-IN-1 | / | Unkown | |
| HY-182046 | HD202A | / | Unkown | |
| HY-182939 | MNK1/2-IN-10 | Inhibitor | / | Unkown |
| HY-182957 | MNK/PIM-IN-2 | / | Unkown | |
| HY-184004 | NUCC-0231068 | Inhibitor | / | Unkown |
| HY-RS04275 | EIF4E2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04276 | EIF4E3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W846144 | ETP-45835 | Inhibitor | / | Unkown |
| HY-119271A | (-)-CMLD010509 | / | Unkown | |
| HY-139098 | 7-Methyl-diguanosine triphosphate | / | Unkown | |
| HY-145974 | m7GpppAmpG | / | Unkown | |
| HY-168326 | Antiproliferative agent-64 | Inhibitor | / | Unkown |
| HY-172457 | NUCC-0200808 | Inhibitor | / | Unkown |
| HY-182704 | SBI-5844 | Inhibitor | / | Unkown |
| HY-RS17829 | Eif4e Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24297 | Eif4e Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service